Covestor’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
Other funds holding ACAD
Covestor's ACAD Position: Q3 2026 in Review
Covestor sold out of Acadia Pharmaceuticals (ACAD) in Q3 2026, closing a stake of 4,682 shares — an estimated $118K sold.
Covestor first reported a position in ACAD in Q4 2021 and held it in 19 quarters. The position peaked at $345K in Q2 2025. 263 funds tracked by Wall St. Rank hold ACAD as of Q3 2026.
- Covestor reported no remaining Acadia Pharmaceuticals position as of Q3 2026 after selling out during the quarter.
- Covestor sold 4,682 Acadia Pharmaceuticals shares in Q3 2026, an estimated $118K.
- Covestor first reported a position in Acadia Pharmaceuticals in Q4 2021 and held it in 19 quarters.
- Covestor's Acadia Pharmaceuticals position peaked at $345K in Q2 2025.
- 263 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q3 2026.
Based on Covestor's 13F filing for Q3 2026, filed 30 Oct 2026.